Most Searched
Our skilled eye care specialists offer state-of-the-art glaucoma diagnostics and treatments.
Telehealth appointments are available.
Glaucoma is an eye condition that damages your optic nerve. It is the leading cause of irreversible blindness worldwide. Glaucoma damages the nerve that connects the eye and brain, resulting in vision loss. The condition affects your side vision (peripheral vision) first, so early on, you may not have any symptoms. The sooner you are diagnosed and treated the greater the chances of saving your vision.
Our eye experts use the most advanced treatment techniques for every type of glaucoma, including:
Glaucoma can affect anyone, but if you are over age 60 or have a family history of glaucoma, you are at higher risk. When glaucoma first begins, you may not experience any symptoms. But over time, as the disease progresses, you’ll begin to lose your peripheral vision.
Symptoms of glaucoma include:
By the time your symptoms become noticeable, significant damage to the optic nerve may have occurred. This is why regular eye checkups are important, especially if you are over age 40.
Our ophthalmologists have helped pioneer many life-changing glaucoma treatments. We offer a wide range of traditional and cutting-edge treatment options, including prescription eye drops, noninvasive laser treatment, minimally invasive glaucoma surgery (MIGS), traditional glaucoma surgery and drug delivery implants, to help manage your glaucoma and prevent vision loss.
Our team of eye care specialists is at the forefront of advancements in glaucoma diagnosis and treatment.
One of the treatments we offer involves the XEN Gel Stent, a tiny drainage stent, approximately the width of a human hair, that can be inserted and lower your eye pressure in just a few minutes.
We conduct extraordinary research to support our commitment to ending vision loss and blindness.
We are one of the top institutes in the United States for our ability to attract research funding.
Showing 4 locations
Showing 3 locations
LOS ANGELES — New research published in JAMA Network Open from Read more